This article is for informational purposes only and is not medical advice. Full disclaimer →
In one sentence: In laboratory testing, the same soap ingredient inactivates SARS-CoV-2 and influenza virus through thermodynamically opposite mechanisms — a flip the paper attributes to the viruses' ~100-fold difference in surface protein density.
Yamamoto A, Iseki Y, et al. · Scientific reports (2026)
PubMed 41588045 · DOI · PMC full text
Why this paper matters
The paper shows that specific soap ingredients engage fundamentally different molecular mechanisms against SARS-CoV-2 versus influenza, with the 'best' mechanism flipping between the two viruses. For a site focused on monolaurin, the directly relevant finding is that potassium laurate (C12:0-K, the lauric-acid salt closest in structure to monolaurin) was the least effective compound tested against SARS-CoV-2 — challenging generalizations that C12 compounds are uniformly superior antimicrobials. Atomic-resolution binding targets and the behavior of these surfactants in real-world matrices (serum proteins, skin oils) both remain open questions the authors explicitly flag.
Background
Handwashing with soap is a frontline defense against enveloped viruses like SARS-CoV-2. Soaps contain surfactants—both natural fatty acid salts (potassium oleate, potassium laurate, potassium myristate) and synthetic compounds (SDS, SLES). A prior 2018 study by the same research group (Kawahara et al., PLoS One) showed that potassium oleate (C18:1-K) inactivated influenza virus far more effectively than synthetic surfactants. That study used ITC to characterize the thermodynamic mechanism, finding that C18:1-K and SDS both showed negative ΔH values against influenza (indicating endothermic electrical interactions with hemagglutinin proteins), while SLES showed a positive ΔH indicating exothermic hydrophobic interaction—and SLES was far less effective, suggesting hydrophobic envelope disruption alone is insufficient against influenza.
A January 2026 paper in Scientific Reports (Yamamoto et al.) reveals that when C18:1-K encounters SARS-CoV-2, the thermodynamic signature is reversed: it shows a positive ΔH (endothermic hydrophobic interaction), the same profile that was associated with ineffective inactivation against influenza. Yet C18:1-K is the most potent compound tested against SARS-CoV-2. This paradox—endothermic hydrophobic interaction is powerful against one coronavirus but not influenza—has immediate implications for understanding how viral surface architecture determines which disinfectant mechanisms actually work. With ongoing concerns about pandemic preparedness and endemic coronavirus circulation, this molecular-level understanding is urgently relevant.
The Potency Ranking
One natural soap ingredient outperforms every synthetic detergent tested—by a factor of six to sixteen.
Potassium oleate (C18:1-K) achieved 99% SARS-CoV-2 inactivation at just 0.239 mM, compared to 1.45 mM for SDS and 2.80 mM for SLES.[1, 2] The IC₉₉ values reveal that C18:1-K is approximately 6× more potent than SDS (1.45/0.239) and approximately 12× more potent than SLES (2.80/0.239). This ranking—C18:1-K > SDS > SLES > C14:0-K ≥ C12:0-K—was consistent across IC₅₀, IC₉₉, and IC₉₉.₉₉ measurements, making the pattern robust rather than a threshold artifact. Separately, at its own IC₉₉, C18:1-K is approximately 16× more potent than C12:0-K (3.83/0.239).
Shorter-chain fatty acid salts—potassium laurate (C12:0-K) and potassium myristate (C14:0-K)—were less effective against SARS-CoV-2 than the synthetic surfactants SDS and SLES, with IC₉₉ values of 3.83 mM and 2.95 mM respectively.[1, 2] C12:0-K was the weakest performer, roughly 16× less potent than C18:1-K at the IC₉₉ level. The carbon chain length and the presence of a cis-double bond in oleate (C18:1) appear to be critical determinants of potency. A saturated 16-carbon compound, C16:0-K, could not be tested due to low aqueous solubility; the source paper notes C16:0-K had low solubility. Note: the primary paper labels C14:0-K as 'potassium palmitate,' though chemically C14:0 is myristic acid and C16:0 is palmitic acid—this nomenclature appears to be an internal convention of the source paper and should not be taken as standard chemical nomenclature.
The antiviral assay used a 3-minute incubation at approximately 25°C, a standard virucidal testing protocol using serum-free DMEM as the virus diluent.[1] The 3-minute contact time reflects a standard protocol for virucidal efficacy testing rather than a direct simulation of handwashing (WHO/CDC guidelines recommend 20 seconds of active scrubbing). Importantly, the assay used serum-free DMEM, whereas some comparator studies used serum-containing media; the absence of serum proteins may affect how surfactants interact with virus particles and limits direct comparison with real-world conditions where organic matter is present.
The Mechanistic Surprise
Against influenza, C18:1-K binds proteins electrostatically. Against SARS-CoV-2, the same molecule attacks the lipid membrane hydrophobically. Same molecule, opposite physics.
SDS and potassium laurate (C12:0-K) showed negative ΔH values with SARS-CoV-2, indicating exothermic electrostatic interactions—the same type of mechanism that made C18:1-K potent against influenza, but here it is less effective.[1, 5] The thermodynamic profiles of SDS and C12:0-K against SARS-CoV-2 were the mirror image of C18:1-K: both released heat (exothermic, negative ΔH). The authors interpret this as electrostatic binding between the surfactants' charged headgroups and viral surface proteins. TEM imaging corroborated this, showing that SDS and C12:0-K frequently caused physical rupture of viral particle membranes. A 2022 follow-up influenza study by Kawahara et al. (PMID 35782784) using ITC and SAXS confirmed that fatty acid salts form highly ordered, exothermic complexes with influenza hemagglutinin proteins, further supporting the protein-targeting mechanism.
SLES showed near-zero enthalpy change against SARS-CoV-2, yet still caused significant membrane rupture visible by TEM—grouping it with the 'electrostatic interaction' surfactants despite its ambiguous thermodynamic signature.[1] Despite producing minimal heat signal in ITC, SLES still caused considerable viral particle deformation and rupture in TEM images, and the primary paper groups SLES together with SDS and C12:0-K as the 'electrostatic interaction group' associated with rupture morphology. The authors interpret SLES's near-zero ΔH as a potential cancellation of endothermic hydrophobic and exothermic electrostatic contributions. However, this interpretation is inferential; the mechanistic classification of SLES is the most uncertain of all compounds tested.
The Spike Protein Paradox
SARS-CoV-2 has roughly 100 times fewer surface proteins per unit area than influenza—and that exposed membrane is exactly where potassium oleate attacks.
SARS-CoV-2 has approximately 26 ± 15 spike protein trimers per particle (~1 per 1,000 nm² of surface), versus influenza's ~300–400 HA protein trimers (~100 per 1,000 nm²)—a roughly 100-fold difference in surface protein density.[1, 10] This ~100-fold difference in surface protein density is the proposed explanation for why potassium oleate uses different mechanisms against the two viruses. With influenza, the dense forest of HA proteins provides abundant electrostatic targets. With SARS-CoV-2, the sparse spike distribution (with large uncertainty—the ±15 represents nearly 60% relative uncertainty) leaves vast expanses of lipid bilayer exposed, making the envelope itself the primary target for hydrophobic attack. The 26-trimer figure comes from cryo-electron tomography studies cited in the primary paper; independent structural estimates from Ke et al. (Scripps, 2020) using cryo-ET on intact virions provide supporting data.
The nonionic surfactant NP-40, which lacks a charged headgroup and cannot form electrostatic interactions, caused almost no viral particle rupture—confirming that rupture is driven by charged surfactant–protein electrostatic interactions, not merely general membrane disruption.[1, 6] NP-40 served as a critical mechanistic control. Despite being a surfactant capable of disrupting lipid membranes, the near-absence of ruptured particles in NP-40-treated samples provided strong evidence that the 'rupture' morphology seen with SDS and C12:0-K requires electrostatic interaction with viral surface proteins. An independent study on feline coronavirus (FCoV) corroborated this: ionic surfactants (SDS, cetylpyridinium chloride) predominantly targeted spike proteins, while the nonionic surfactant C10EO8 disrupted the lipid envelope without the same rupture pattern.
What the Microscope Reveals
Seven distinct ways a virus can die—and each surfactant has its own kill signature under the electron microscope.
Researchers classified surfactant-damaged SARS-CoV-2 into seven morphological categories, from intact particles to complex 3D aggregates, by analyzing approximately 100 particles per condition by TEM.[1] The seven categories were: Normal, Aggregation 1 (clusters of intact particles), Deformation (shape-altered), Aggregation 2 (clusters of deformed particles), Rupture (membrane-damaged), Aggregation 3 (membrane-fused aggregates), and Aggregation 4 (complex 3D aggregates). This systematic classification enabled quantitative comparison of how different surfactants physically destroy virions. The ~100-particle sample size per condition is a modest count for quantitative morphological analysis and is acknowledged as a limitation.
At 1 mM, C18:1-K caused 38% of particles to form membrane-fused aggregates (Aggregation 3)—the visual fingerprint of its hydrophobic lipid-targeting mechanism—while SDS and C12:0-K produced predominantly ruptured particles.[1] Membrane-fusion aggregation is the morphological correlate of C18:1-K's hydrophobic interaction: rather than punching holes in individual virions, the long-chain oleate penetrates and destabilizes lipid bilayers, causing neighboring viral envelopes to fuse into non-infectious masses. The contrast with SDS- and C12:0-K-treated samples, which showed predominantly rupture, visually confirms the two distinct mechanistic pathways detected thermodynamically.
In saline controls, 63.6% of SARS-CoV-2 particles appeared morphologically normal, with only 4.5% showing rupture and 3.4% showing membrane fusion, establishing the baseline for measuring surfactant-induced damage.[1] The control distribution showed that the dramatic morphological changes in surfactant-treated groups were caused by the surfactants rather than sample preparation artifacts. The baseline rupture rate of 4.5% also confirms that the much higher rupture rates observed with SDS and C12:0-K are genuine treatment effects.
From Bench to Bottle: Implications and Limitations
This research reframes what 'good soap' means—but real-world validation is still far away.
The critical micelle concentration (CMC) of C18:1-K in physiological saline (0.9% NaCl) is 0.4 mM—higher than its IC₉₉ of 0.239 mM—meaning viral inactivation occurs at sub-micellar concentrations.[1, 9] CMC is the concentration at which surfactant molecules spontaneously self-assemble into micelles. C18:1-K's CMC of 0.4 mM in saline exceeds its IC₉₉ of 0.239 mM, indicating that monomeric or pre-micellar forms of the surfactant (not fully formed micelles) are the primary active species for viral inactivation. The primary paper frames this as evidence that hydrophobicity drives membrane disruption at concentrations below full micelle formation. This contrasts with the traditional assumption that micelle formation is required for effective virus inactivation—a point also made by a 2023 MDPI study on detergent-mediated inactivation in biotechnological matrices.
The entire study used a single early-pandemic SARS-CoV-2 strain (JP/Hiroshima-46059T/2020, lineage B.1.1) in serum-free conditions; results may not generalize to variants of concern with structurally altered spike proteins or to real-world matrices containing organic matter.[1, 11] Variants like Omicron have substantially remodeled spike proteins with altered receptor-binding and fusion properties, as documented in structural studies (Cell Reports, 2022). If spike protein density or surface architecture differs between variants, the mechanistic balance between hydrophobic and electrostatic inactivation could shift. The authors explicitly call for future molecular docking, molecular dynamics simulations, and STD-NMR spectroscopy to confirm atomic-level binding sites—current mechanistic conclusions are inferred from bulk thermodynamics, not direct structural evidence.
An independent study on feline coronavirus (FCoV) corroborates the primary paper's finding: ionic surfactants (SDS, cetylpyridinium chloride) predominantly targeted spike proteins, while the nonionic C10EO8 disrupted the lipid envelope.[6, 7] The FCoV study (PMID 38364478) used fluorescence spectroscopy, dynamic light scattering, laser Doppler electrophoresis, and liposome permeability experiments—entirely different methods from the ITC/TEM approach of the primary paper—and reached convergent conclusions about ionic surfactants targeting surface proteins. This cross-virus, cross-method corroboration strengthens confidence in the general principle. FCoV is used as a safer model for pathogenic coronaviruses, though its spike protein density relative to SARS-CoV-2 has not been directly compared in either paper.
Potassium oleate's antiviral and antibacterial performance is protected by patents in Japan, Russia, Korea, and China (per the prior 2018 Kawahara paper). One of the 2026 paper's nine co-authors, Takayoshi Kawahara, is affiliated with Shabondama Soap Co., Ltd. — the Japanese natural soap manufacturer holding those patents — though the paper formally declares no competing interests. The 2026 study itself was funded by the Satake Technical Foundation and Japan's AMED, not by Shabondama.[1, 3] The anti-viral effect of C18:1-K is patented in multiple countries according to the prior influenza paper (Kawahara et al., 2018). The 2026 study's nine-author team includes a researcher affiliated with the patent-holding company, which is a potential conflict of interest worth weighing when interpreting the results. However, the 2026 paper itself is funded by public/foundation grants (Satake Technical Foundation + AMED Japan) rather than Shabondama, the mechanistic findings are internally consistent, and they are corroborated by independent FCoV research (Mateos et al. 2024) using entirely different methods and funders.
Caveats and open questions
What this paper doesn't settle
The exact binding targets on SARS-CoV-2 at atomic resolution are unresolved. Mechanistic conclusions are inferred from bulk thermodynamic (ITC) and morphological (TEM) data. The authors explicitly call for molecular docking, MD simulations, and STD-NMR to confirm binding sites—none of these confirmatory studies have yet been done. The spike protein density figures for SARS-CoV-2 carry substantial uncertainty (26 ± 15 trimers per virion, nearly 60% relative uncertainty). The mechanistic 'flip' between viruses depends critically on the prior influenza ITC findings (Kawahara et al. 2018), and the thermodynamic interpretation of that comparison requires careful reading of both papers' sign conventions and experimental conditions.
The honest skeptical read
This is an in vitro study using a single early-pandemic SARS-CoV-2 strain (B.1.1, 2020) in serum-free DMEM. Real-world handwashing involves complex organic matrices—skin oils, dirt, serum proteins—that could substantially alter surfactant behavior. The ITC experiments were conducted at a single surfactant concentration (0.175 mM) that is below the IC₉₉ for most compounds tested, so whether the thermodynamic mechanisms observed at low concentration fully explain inactivation at higher concentrations remains uncertain. One of the paper's co-authors is affiliated with Shabondama Soap Co., the Japanese soap manufacturer holding patents on potassium oleate's antiviral properties, which is a conflict of interest worth noting despite the authors' formal no-competing-interests declaration. Independent replication using different methods has corroborated the mechanistic core (see Mateos et al. 2024 on feline coronavirus).
Common misconception
Potassium laurate (C12:0-K) was the least effective surfactant tested against SARS-CoV-2, roughly 16× less potent than potassium oleate. This directly challenges narratives about C12 fatty acid compounds being broadly superior antimicrobials—though importantly, this study tests the potassium salt of lauric acid, not monolaurin (glycerol monolaurate), which has a different molecular structure and mechanism. The antimicrobial properties of C12 compounds against bacteria do not necessarily translate to antiviral potency against coronaviruses.